This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Adaerata, Limited Partnership. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Marine Lacomme: Innovator in Neuronal Health
Introduction
Marine Lacomme is a prominent inventor based in Montréal, Canada. She has made significant contributions to the field of neuroscience, particularly in the area of neuronal health and degradation.
Latest Patents
Marine Lacomme holds a patent for a method of reducing neuronal microtubule binding protein Tau (Tau) levels. This innovative method promotes neuronal Tau degradation and enhances neuronal survival in subjects in need. The process involves contacting the neurons with an effective amount of an agent that increases the expression and/or activity of a long phosphotyrosine-binding (PTB) Numb isoform. This approach effectively reduces neural Tau levels, promoting both degradation and survival compared to conditions without the agent.
Career Highlights
Marine Lacomme is associated with Adaerata, Limited Partnership, where she continues to advance her research and innovations. Her work has the potential to impact treatments for neurodegenerative diseases, making her a key figure in the field.
Collaborations
Marine collaborates with Michel Cayouette, further enhancing her research efforts and contributions to neuroscience.
Conclusion
Marine Lacomme's innovative work in reducing Tau levels represents a significant advancement in neuronal health. Her contributions are poised to influence future therapeutic strategies in neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile